🔎 Trials Near Me

Dachaigh › Tumor Wilms › California

Sgrùdaidhean clionaigeach Tumor Wilms ann an California

Tha 5 sgrùdaidhean airson Tumor Wilms a’ lorg phàirtichean aig làraichean ann an California.

Bailtean ann an California

Teacsa sgrùdaidh oifigeil (Beurla)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • Children's Hospital Los Angeles, Los Angeles
  • Lucile Packard Children's Hospital Stanford University, Palo Alto
A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT04616560

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital of Orange County, Orange
  • UCSF Medical Center-Mission Bay, San Francisco
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • Kaiser Permanente Downey Medical Center, Downey
  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • agus 11 a bharrachd
A’ fastadhÌre 2
Suas gu aois 30 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04322318

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Lucille Packard Children's Hospital Stanford, Palo Alto
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04901702

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

  • Children's Hospital of Los Angeles (Data Collection Only), Los Angeles
  • Stanford Medicine Children's Health (Data Collection Only), Palo Alto
A’ fastadhÌre 2
12 Months · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT05985161

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.